Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 201
of 11Next
1:

New approaches to combating antimicrobial drug resistance.

Avison MB.

Genome Biol. 2005;6(13):243. Epub 2005 Dec 23. Review.

PMID: 16420675 [PubMed - indexed for MEDLINE]

2:

An antibiotic resistance fighter.

Stix G.

Sci Am. 2006 Apr;294(4):80-3. No abstract available.

PMID: 16596883 [PubMed - indexed for MEDLINE]

3:

Microbiology. Noninherited resistance to antibiotics.

Levin BR.

Science. 2004 Sep 10;305(5690):1578-9. No abstract available.

PMID: 15361616 [PubMed - indexed for MEDLINE]

4:

Antibiotic interactions that select against resistance.

Chait R, Craney A, Kishony R.

Nature. 2007 Apr 5;446(7136):668-71.

PMID: 17410176 [PubMed - indexed for MEDLINE]

5:

Inhibition of mutation and combating the evolution of antibiotic resistance.

Cirz RT, Chin JK, Andes DR, de Crécy-Lagard V, Craig WA, Romesberg FE.

PLoS Biol. 2005 Jun;3(6):e176. Epub 2005 May 10.

PMID: 15869329 [PubMed - indexed for MEDLINE]

6:

Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria.

Cirz RT, Romesberg FE.

Antimicrob Agents Chemother. 2006 Jan;50(1):220-5.

PMID: 16377689 [PubMed - indexed for MEDLINE]

7:

[Activation of the alarm response of Escherichia by antibiotics]

Tets VV, Shafkhid MG.

Zh Mikrobiol Epidemiol Immunobiol. 1990 Sep;(9):10-5. Russian.

PMID: 2124020 [PubMed - indexed for MEDLINE]

8:

Sublethal concentrations of ciprofloxacin induce bacteriocin synthesis in Escherichia coli.

Jerman B, Butala M, Zgur-Bertok D.

Antimicrob Agents Chemother. 2005 Jul;49(7):3087-90.

PMID: 15980407 [PubMed - indexed for MEDLINE]

9:

Zeocin resistance suppresses mutation in hypermutable Escherichia coli.

Bostock JM, Miller K, O'Neill AJ, Chopra I.

Microbiology. 2003 Apr;149(Pt 4):815-6. Review. No abstract available.

PMID: 12686623 [PubMed - indexed for MEDLINE]

10:

Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.

Olofsson SK, Marcusson LL, Komp Lindgren P, Hughes D, Cars O.

J Antimicrob Chemother. 2006 Jun;57(6):1116-21. Epub 2006 Apr 19.

PMID: 16624874 [PubMed - indexed for MEDLINE]

11:

Microbiology: RAMP resistance.

Buckling A, Brockhurst M.

Nature. 2005 Nov 10;438(7065):170-1. No abstract available.

PMID: 16281021 [PubMed - indexed for MEDLINE]

12:

Phenotypic and genotypic characterization of antimicrobial resistance in Escherichia coli O111 isolates.

Guerra B, Junker E, Schroeter A, Helmuth R, Guth BE, Beutin L.

J Antimicrob Chemother. 2006 Jun;57(6):1210-4. Epub 2006 Apr 7.

PMID: 16603644 [PubMed - indexed for MEDLINE]

13:

Experimental evolution of resistance to an antimicrobial peptide.

Perron GG, Zasloff M, Bell G.

Proc Biol Sci. 2006 Jan 22;273(1583):251-6.

PMID: 16555795 [PubMed - indexed for MEDLINE]

14:

Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin.

Cirz RT, Jones MB, Gingles NA, Minogue TD, Jarrahi B, Peterson SN, Romesberg FE.

J Bacteriol. 2007 Jan;189(2):531-9. Epub 2006 Nov 3.

PMID: 17085555 [PubMed - indexed for MEDLINE]

15:

Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.

Sorlozano A, Gutierrez J, Jimenez A, de Dios Luna J, Martínez JL.

J Clin Microbiol. 2007 Aug;45(8):2740-2. Epub 2007 Jun 13.

PMID: 17567787 [PubMed - indexed for MEDLINE]

16:

Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli.

López E, Elez M, Matic I, Blázquez J.

Mol Microbiol. 2007 Apr;64(1):83-93.

PMID: 17376074 [PubMed - indexed for MEDLINE]

17:

Induction of the SOS response by new 4-quinolones.

Phillips I, Culebras E, Moreno F, Baquero F.

J Antimicrob Chemother. 1987 Nov;20(5):631-8.

PMID: 3323160 [PubMed - indexed for MEDLINE]

18:

Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.

Pasquali F, Manfreda G.

Vet Microbiol. 2007 Jan 31;119(2-4):304-10. Epub 2006 Aug 17.

PMID: 16987619 [PubMed - indexed for MEDLINE]

19:

Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure.

Skurnik D, Le Menac'h A, Zurakowski D, Mazel D, Courvalin P, Denamur E, Andremont A, Ruimy R.

Antimicrob Agents Chemother. 2005 Jul;49(7):3062-5.

PMID: 15980401 [PubMed - indexed for MEDLINE]

20:

Antimicrobial resistance in commensal Escherichia coli isolated from muscle foods as related to the veterinary use of antimicrobial agents in food-producing animals in Austria.

Mayrhofer S, Paulsen P, Smulders FJ, Hilbert F.

Microb Drug Resist. 2006 Winter;12(4):278-83.

PMID: 17227214 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 201
of 11Next